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Abstract
In Gram-positive bacteria, the transcriptional regulator CcpA is at the core of catabolite control mechanisms. In the human
pathogen Streptococcus pneumoniae, links between CcpA and virulence have been established, but its role as a master
regulator in different nutritional environments remains to be elucidated. Thus, we performed whole-transcriptome and
metabolic analyses of S. pneumoniae D39 and its isogenic ccpA mutant during growth on glucose or galactose, rapidly and
slowly metabolized carbohydrates presumably encountered by the bacterium in different host niches. CcpA affected the
expression of up to 19% of the genome covering multiple cellular processes, including virulence, regulatory networks and
central metabolism. Its prevalent function as a repressor was observed on glucose, but unexpectedly also on galactose.
Carbohydrate-dependent CcpA regulation was also observed, as for the tagatose 6-phosphate pathway genes, which were
activated by galactose and repressed by glucose. Metabolite analyses revealed that two pathways for galactose catabolism
are functionally active, despite repression of the Leloir genes by CcpA. Surprisingly, galactose-induced mixed-acid
fermentation apparently required CcpA, since genes involved in this type of metabolism were mostly under CcpA-
repression. These findings indicate that the role of CcpA extends beyond transcriptional regulation, which seemingly is
overlaid by other regulatory mechanisms. In agreement, CcpA influenced the level of many intracellular metabolites
potentially involved in metabolic regulation. Our data strengthen the view that a true understanding of cell physiology
demands thorough analyses at different cellular levels. Moreover, integration of transcriptional and metabolic data
uncovered a link between CcpA and the association of surface molecules (e.g. capsule) to the cell wall. Hence, CcpA may
play a key role in mediating the interaction of S. pneumoniae with its host. Overall, our results support the hypothesis that S.
pneumoniae optimizes basic metabolic processes, likely enhancing in vivo fitness, in a CcpA-mediated manner.
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Introduction
The survival of bacterial pathogens in different host environ-
ments depends largely on the expression of specific virulence
factors [1,2], but also on recognition of nutrients and rapid
adaptation to their availability in fluctuating environments.
Human bacterial pathogens are heterotrophs that depend on
carbon sources to generate energy and catabolic intermediates for
growth. In many bacteria, adaptation to changing carbon sources
is accomplished through a regulatory mechanism called carbon
catabolite control (for reviews see [3,4]). At the molecular level,
carbon catabolite control can be achieved through different
regulatory mechanisms, namely transcription activation and
repression of genes by global regulators, control of translation by
RNA-binding proteins, and allosteric regulation, in response to a
preferred carbon source. Overall, these phenomena ensure that
carbon sources yielding a maximum profit for growth are utilized
first.
In low-GC Gram-positive organisms, such as Bacillus subtilis and
Lactococcus lactis, glucose (Glc) is generally the preferred carbohy-
drate and the catabolite control protein A (CcpA) is the main
transcriptional regulator functioning at the core of carbon
catabolite control [5,6]. CcpA binds to DNA at catabolite-
responsive element (cre) sites, the location of which, relative to the
promoter region, determines whether it acts as a transcriptional
inhibitor or activator [5,6]. The cre-binding activity of CcpA is
enhanced by interaction with the phosphoprotein HPr, a
component of the multi-protein phosphoenolpyruvate-dependent
phosphotransferase system (PTS), when phosphorylated at serine
46 (HPr(Ser-P)) by a fructose 1,6-bisphosphate (FBP) activated
kinase [3].
Although the mechanisms by which catabolite control is exerted
are among the most studied in model bacteria, a paucity of data
hampers our understanding on how human pathogens adapt to
different host environments. In the pathogenic Streptococci,
increasing evidence supports key roles of CcpA and HPr(Ser-P)
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of genes in Streptococcus mutans (about 9%) and Streptococcus pyogenes
(up to 20%), including the production of a number of virulence
factors [7,8].
Streptococcus pneumoniae is a major cause of life threatening
diseases including pneumonia, meningitis and septicaemia, as well
as other less severe but highly prevalent infections (e.g. otitis
media). Pneumococcal disease is preceded by colonization of the
human nasopharynx, S. pneumoniae’s natural habitat. It is well
established that progression from carriage to pneumococcal
invasion is associated with changes in expression of virulence
factors, such as capsule and surface proteins [1,2], but the basic
metabolic mechanisms underlying these adaptations remain
elusive. Unrelated studies have clearly shown that CcpA influences
the expression of genes involved in pneumococcal carbohydrate
metabolism [10–12]. Furthermore, CcpA has been implicated in
the regulation of virulence factors, namely expression of genes in
the capsule (cps) locus [11] and was proven necessary for
colonization of the nasopharynx and survival in the lungs [10].
Curiously, CcpA-independent catabolite repression of metabolic
enzymes was a recurrent observation, leading to a view that
minimized the role of CcpA as a master regulator of catabolite
control in S. pneumoniae [10,11].
In this work, the impact of CcpA on pneumococcal physiology
was reappraised by combining genomewide transcriptomics with
metabolite analysis of S. pneumoniae D39 and its isogenic ccpA
mutant. Our approach is in line with the current view that true
understanding of a microbial metabolism requires quantitative
analyses of system components at different cellular levels [13]. A
major question was whether S. pneumoniae regulates expression of
carbohydrate utilization genes and virulence factors in a
carbohydrate-dependent, CcpA-mediated manner. Hitherto, the
information available has largely been limited to the response of a
few specific metabolic genes involved in carbohydrate utilization
[10–12]. For our global studies, Glc and galactose (Gal) were used
as carbon sources for the growth of S. pneumoniae. This choice was
based on the following: Glc is the most common preferred
carbohydrate, and is also found in considerable amounts in the
bloodstream and during infection in the respiratory tract of the
host [14]. Gal, generally a slowly metabolized non-preferred
carbohydrate, was selected among other host-derived carbohy-
drates as this monosaccharide is one of the prevailing carbohy-
drates encountered by the pneumococcus in the human
nasopharynx (colonization state) [15,16]. Our data show that
CcpA influences the expression profile of central and carbohy-
drate-specific metabolic genes of S. pneumoniae as well as virulence
factor-encoding genes in a carbohydrate-dependent and inde-
pendent manner. These results enhance our understanding of
how CcpA-mediated regulation can contribute to the metabolic
fitness of S. pneumoniae in the host, which further supports the view
that virulence and basic microbial physiology are closely
intertwined.
Results
Growth rates on Glc and Gal are differently affected by
CcpA
Hitherto, a systemic appraisal to the role of CcpA in the
physiology of S. pneumoniae was missing. We constructed a S.
pneumoniae ccpA deletion-insertion mutant (D39DccpA, for details see
Material & Methods and Fig. S1A) in the D39 serotype 2
background (Table 1), and determined the growth profiles of the
ccpA mutant and the wild-type D39 in chemically defined medium
(CDM) containing Glc without pH control (Fig. S1B). Under the
conditions studied, the maximal biomass reached at time points
8 h and 14 h for strains D39 and D39DccpA, respectively, was
consistently slightly higher in the absence of CcpA. Loss of CcpA
caused a substantial decrease (about 55%, Table 2) of the growth
rate in Glc-containing CDM. Importantly, this growth rate defect
was fully restored by complementation of a ccpA strain (D39DccpA-
nisRK, m=0.7660.00 h
21) with expression in trans of ccpA under
the control of the nisin promoter (Fig. S1B). It should be noted that
the growth profile of strain D39DccpAnisRK closely resembles that
of D39DccpA (data not shown).
To extend our knowledge on the role of CcpA in the physiology
of S. pneumoniae, growth on galactose was also assessed in batch
cultivations as described for Glc (Fig. S1C). On Gal, the maximal
biomass produced was also similar in both strains. However, in
strong contrast to the effect in Glc-CDM, in Gal-CDM the growth
rate of strain D39DccpA was slightly higher than that of D39,
although this difference was not statistically significant.
Our data show that the effect of CcpA on the growth rate of S.
pneumoniae is carbohydrate-dependent; CcpA noticeably stimulates
fast growth on Glc, but the effect on Gal, if any, is unclear.
CcpA is a pleiotropic regulator in S. pneumoniae
To determine the effect of the ccpA deletion on the transcrip-
tome of S. pneumoniae, the transcriptional profile of D39 wild-type
was compared to that of its isogenic ccpA deletion mutant at mid-
exponential (M) and transition-to-stationary (TS) phases of growth.
In the four conditions tested, Glc_M, Gal_M, Glc_TS, Gal_TS,
between 14 and 19% of the ORFs in the genome were
significantly, differentially expressed in the ccpA deletion mutant,
of which more genes upregulated than downregulated (Fig. 1, see
also Table S1 for an overview). This is similar to S. pyogenes (up to
20% genes affected) [8], but higher than S. mutans, L. lactis, and B.
subtilis (less than 9% genes affected) [5–7]. These findings confirm
the role of CcpA as a global regulator with a prevalent repressor
function.
The COG category with the highest number of genes affected
was carbohydrate transport and metabolism [G], which genes are
mainly repressed by CcpA (Fig. 1B). Also, 21 genes encoding
(putative) transcriptional regulatory proteins were affected, among
which three two-component systems, indicating intertwinement of
CcpA with other regulons. In addition, many genes with unknown
or unpredicted function, as well as a number of genes within the
amino acid transport and metabolism category [E], were among
the differentially expressed genes (see also Table S1).
Strikingly, roughly similar numbers of genes were regulated
when galactose instead of glucose was used as the carbon source
(Fig. 1, Table S1). This means that during growth on the slowly
metabolized galactose, carbon catabolite repression by CcpA still
takes place. Furthermore, a large part of the genes (up to 44% per
condition) differentially expressed were common to all 4
conditions, but carbohydrate and growth phase-specific CcpA-
mediated regulation was also in effect (Fig. 1, Table S1).
To firmly confirm our microarray data, changes in transcript
abundance of selected genes linked to metabolic and virulence
pathways (lacE, galK, pyk, ldh, pfl, sodA, nanA), were assessed by
qRT-PCR. For all genes tested, expression data obtained by qRT-
PCR proved to correlate positively with transcript abundance as
measured by microarray analysis (Table S2).
In summary, the role of CcpA as a master regulator in S.
pneumoniae is undoubtedly substantiated by our genomewide
transcriptome analyses. Curiously, not only Glc, but also
galactose appears in this study as a repressing carbohydrate in
S. pneumoniae.
The Role of CcpA in S. pneumoniae D39
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carbohydrate-dependent and independent manners
The first step in the metabolism of any carbohydrate is transport
across the cell membrane. Genes in 17 out of 29 operons encoding
carbohydrate uptake systems are affected in the ccpA arrays (Table
S3). As for many other categories, several genes encoding
carbohydrate transporters were not only strongly repressed by
CcpA on Glc, but also on Gal. ManLMN (SPD_264-2) codifying
the mannose/glucose-PTS, a predominant Glc transporter in
Streptococcaceae [3], was among them. Carbohydrate-specific CcpA-
mediated regulation was also in effect: SPD_0661, a Glc-family
PTS system, was exclusively repressed in Gal-CDM. This gene is
predicted to be a direct target of CcpA due to the presence of a cre
site in its promoter region. Another PTS operon (SPD_0559-
0562), which also contains a cre site in its promoter region, was
strongly negatively regulated on Glc, but only mildly on Gal.
Table 1. Bacterial strains, plasmids and primers used in this study.
Strain Description Source
S. pneumoniae
D39 Serotype 2 strain, cps2 (MolGen Laboratory collection) [58]
D39DccpA D39 DccpA::spc;S p c
R This work
D39nisRK D39 DbgA::nisRK; Trim
R [50]
D39DccpAnisRK D39 DccpA::spc DbgA::nisRK;S p c
R, Trim
R This work
D39DccpAnisRKpNZ[ccpA] D39 DccpA::spc DbgA::nisRK harbouring pNZ[ccpA]; Spc
R, Trim
R,C m
R This work
L. lactis
MG1363 Plasmid-free L. lactis subsp. cremoris NCDO712 [59]
Plasmids Description
pNZ[ccpA] pNG8048E carrying ccpA downstream of the nisA promoter; Cm
R This work
pNG8048e Nisin-inducible PnisA, pNZ8048 derivative containing em
R to facilitate cloning; Cm
R,E m
R [50]
pNZ8048 Nisin-inducible PnisA;C m
R [60]
pORI38 ori
+ repA
2, deletion derivative of pWV01; Spc
R [61]
Primers Sequence (from 59 to 39) REnz
ccpA_D39_KO-1 CCAATATTCTTTCAAAACTGG -
ccpA_D39_KO-2
a TCCTCCTCACTATTTTGATTAGGGTTACTGTATCATCTGCATTC -
ccpA_D39_KO-3
a CGTTTTAGCGTTTATTTCGTTTAGTCATGGTTTGACAGAACGTAGCTC -
ccpA_D39_KO-4 CCCAGTCGCTCTGGTATCAC -
ccpA_D39-1
b GCCGGTCTCTCATGAATGCAGATGATACAGTAACC BsaI
ccpA_D39-2
b GCTCTAGATCGATTCCCTGATTTTTTCTATTTACG XbaI
Spec_Fp CTAATCAAAATAGTGAGGAGG -
Spec_Rp ACTAAACGAAATAAACGC -
Spd_0420-qRT-1 TGGGAAGGCTTCAAAGG -
Spd_0420-qRT-2 GGACGAGTGTCCATTGG -
Spd_0667-qRT-1 TCCATATGCATACGACGC -
Spd_0667-qRT-2 TGGGATAGATTCTACATCAGC -
metG-D39-2 TTCTGCCAGCTGGCTTTC -
metG_D39-1 ATCCGTACAACTGATGAC -
Spd_0790-qRT-1 GGTGAGGACGGATACTGG -
Spd_0790-qRT-2 TAACAGTTGCCATACGCTC -
Spd_1053-qRT-1 GTGCAGATGCTGCAGG -
Spd_1053-qRT-2 GGCCACGAGTCATATAAGC -
Spd_1078-qRT-1 TTGACCTTAGTCACGCCC -
Spd_1078-qRT-2 TTACCTACAAGGTCAAGACGAG -
Spd_1504-qRT-1 ATGAAACTCAACTTTCGGG -
Spd_1504-qRT-2 GACATTTTCCAAATCTCGTG -
Spd_1634-qRT-1 CTGAAACTCTTCGCAAAGAC -
Spd_1634-qRT-2 TGCGCCGTATGTTCC -
Abbreviations: Spc
R, spectinomycin resistance; Trim
R, trimethoprim resistance; Cm
R, chloramphenicol resistance; Em
R, erythromycin resistance; REnz, restriction
enzyme.
aOverlap with Spc
R gene is indicated in bold.
bRestriction enzyme sites are underlined.
doi:10.1371/journal.pone.0026707.t001
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A genome survey of S. pneumoniae indicates that it possesses both
the Leloir and tagatose 6-phosphate Gal catabolic pathways.
Interestingly, the Leloir genes were repressed by CcpA indepen-
dently of the carbohydrate, whereas the tagatose 6-phosphate
pathway was weakly repressed by CcpA on Glc and strongly
activated on Gal (Fig. 2). Also of note was the observed induction
of the tagatose 6-phosphate pathway (10- to 12-fold higher) and
the Leloir genes galK and galT-2 (25 times higher) by Gal,
regardless of CcpA (Table S4). As for the lac genes, other
intracellular carbohydrate-specific metabolic steps were subjected
to CcpA-mediated regulation in a carbohydrate dependent
manner (Table S1). For example, a putative 1-pfk (SPD_0772)
and an upstream lacR were upregulated in the ccpA mutant only on
Gal.
Cre site prediction in the genome of S. pneumoniae
To discern between direct and indirect CcpA dependent effects,
an in silico cre site prediction was performed in the genome
sequence of D39 (for details see Materials & Methods), yielding 90
predicted cre sites that match with the genes differentially expressed
in the ccpA DNA microarray data in at least one condition (see
Tables S1, S5 and S6). A consensus cre is shown in Fig. S1A. A
rough estimation of operons in S. pneumoniae using Genome2D
[17], based on sizes of intergenic regions and gene orientation,
resulted in the division of the differentially expressed genes in 215
transcriptional units. This means that approximately 42% of the
promoters regulated in the arrays have a cre site and may therefore
be directly regulated by CcpA. When considering only the genes
with a cre site in their promoter region, 68 genes (76%) have a cre
site in a position that agrees with the observed regulation in the
DNA microarray analysis (see Table S1). For the remaining genes,
either the promoter could not be predicted or regulation was weak
and opposite when comparing the different conditions. Notably,
there were many genes with a cre site in their promoter region that
were not affected by the ccpA deletion (Table S6). On the other
hand, the expression of some genes was highly changed, although
a cre site was not found. This suggests indirect regulation of these
genes, possibly by regulators that are influenced by CcpA.
CcpA is by large an activator of glycolysis and influences
genes involved in fermentation
The role of CcpA in controlling expression of genes involved in
central carbon metabolism is well established [5,6,8]. Despite its
prevalent repressor function, in S. pneumoniae CcpA was shown to
activate several glycolytic genes (Fig. 2). The larger positive effects
were observed for the key glycolytic gene pfkA (6-phosphofructo-
kinase) and in ldh (lactate dehydrogenase), but activation of pyk
(pyruvate kinase) was also considerable, which strongly suggests a
predominant role of CcpA in assuring the efficient conversion of
carbohydrates to lactate in this bacterium.
In line, CcpA was in all instances a repressor of pfl (SPD_0420,
pyruvate formate-lyase), which encodes a key activity that directly
competes with lactate dehydrogenase for pyruvate, as well as of pfl-
AE (pyruvate formate-lyase activating enzyme) (Fig. 2, Table S1).
Carbohydrate-independent CcpA-dependent regulation of genes
linked to the pyruvate node has been previously reported [18].
Moreover, the genes in the pathway leading to acetate, pta
(SPD_0985, phosphotransacetylase) and ackA, (SPD_1853, acetate
kinase) were upregulated in the mutant. Curiously, adh
(SPD_1834, alcohol dehydrogenase) was also repressed by CcpA,
but only in Glc containing medium. Moreover, in the parent strain
D39 the expression of pfl, pfl-AE and adh was induced by Gal, as
denoted by the decimal fold change ratio Glc/Gal (Table S4).
Overall, the expression pattern of genes involved in fermentative
Table 2. Product yields, carbon and redox balances, growth and energetic parameters, total substrate and pH values determined
at the time point of maximal biomass achieved by D39 and D39DccpA strains cultured on Glc (5661 mM) or Gal (5761 mM).
Glc Gal
D39 D39DccpA D39 D39DccpA
Product yields
Lactate 1.8660.02 1.7160.01 1.0160.04 1.7860.06
Formate 0.0460.0 0.2060.01 0.8960.00 0.1460.02
Acetate BDL 0.1260.01 0.4960.01 0.1560.02
Ethanol BDL 0.0560.01 0.4560.02 0.0360.00
qs
max (mmol g
21 h
21) 31.462.8 9.662.0 10.062.0 9.861.5
mmax (h
21) 0.7560.03 0.3560.01 0.2760.03 0.3160.01
Carbon balance
a 95619 5 619 5 629 6 64
Redox balance
b 93619 0 629 6 619 2 62
Biomass yield (g mol
21 of substrate) 23.160.5 30.361.1 38.061.7 41.861.9
ATP yield (mol mol
21 of substrate) 1.8660.02 2.0060.05 2.4560.00 2.1060.01
YATP (g of biomass mol
21 of ATP) 12.460.3 15.160.2 15.560.7 19.860.8
Consumed substrate (%) 50614 2 622 6 623 1 60
pH (growth arrest) 5.460.1 5.560.0 5.360.0 5.360.1
Substrate consumption rate and the specific growth rate are also shown. Values of two or three independent experiments were averaged and errors are reported as
6SD.
aCarbon balance is the percentage of carbon in metabolized Glc or Gal that is recovered in the fermentation products (lactate, formate, ethanol and acetate);
bredox balance is the ratio between [lactate]+26[ethanol] and 26[Glc or Gal] multiplied by 100. qs
max was estimated from a first-order derivative of a polynomial fit of
the observed substrate consumption time series. Dry weight (DW) was used as a measure of cell mass. BDL, below detection limit.
doi:10.1371/journal.pone.0026707.t002
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genes) (Fig. 2) strengthens the view that the pneumococcal CcpA
promotes homolactic fermentation.
Loss of CcpA changes the fermentation profiles of D39
on Glc and Gal
The dissimilar growth of D39 and D39DccpA and the resulting
expression profiles prompted us to perform an in-depth charac-
terization of the fermentation patterns on Glc and Gal.
Substrate consumption and end-products. The pneu-
mococcal strains were grown as above. Substrate consumption
and concentrations of end-products are shown in Fig. 3. During
growth on Glc strain D39 showed a typical homolactic
behaviour, the major end-product being lactate, which reached
a concentration of 5261 mM at the time of growth arrest
(maximal biomass), accounting for 93% of the Glc consumed
(Table 2); formate was also formed in minor amounts (Fig. 3A
and Table 2). Loss of CcpA caused a shift towards a more mixed
acid fermentation: a 5-fold increase in the yields of formate, as
well as formation of acetate and ethanol, were accompanied by a
decrease on lactate production, which accounted for 85% of the
Glc consumed as compared to 93% in D39 (Fig. 3B and Table 2).
Hydrogen peroxide (H2O2), a known minor end-product of
streptococcal aerobic metabolism, was also detected. In the wild-
type, the maximal concentration reached was about 0.046
0.002 mM, while in the mutant this concentration was circa 7-fold
enhanced. The low concentrations measured most likely reflect
a limitation in oxygen availability due to the nearly anaerobic
conditions used for growth. At thet i m ep o i n to fg r o w t ha r r e s t ,
the ccpA mutant had consumed 8% less Glc, and the maximal
consumption rate was about 30% of the wild-type level (Table 2).
The observed decrease in Glc consumption was paralleled by
the reduction in growth rate, which was 53% lower in
D39DccpA.
Figure 1. Genes differentially expressed due to inactivation of CcpA. A. Venn diagram of the genes significantly differentially transcribed
due to loss of CcpA. Transcript levels in D39DccpA were compared to D39 wild-type in Glc_M, Gal_M, Glc_TS, Gal_TS as generated by VENNY (http://
bioinfogp.cnb.csic.es/tools/venny/index.html). For all intersections, which are not drawn to scale, the numbers of genes are indicated. The total
number of genes influenced in each condition tested was: Glc_M, 334 (15.3%), Glc_TS, 418 (19.2%), Gal_M, 299 (13.7%), and Gal_TS 299 (13.7%) in a
universe of 2177 genes in the genome of S. pneumoniae. B. Numbers of genes significantly differently transcribed by the ccpA deletion in strain D39
ordered by COG categories. White bars represent M phase of growth, black bars TS phase of growth. [C] Energy production and conversion; [D] Cell
cycle control, cell division; chromosome partitioning; [E] Amino acid transport and metabolism; [F] Nucleotide transport and metabolism; [G]
Carbohydrate transport and metabolism; [H] Coenzyme transport and metabolism; [I] Lipid transport and metabolism; [J] Translation, ribosomal
structure and biogenesis; [K] Transcription; [L] Replication, recombination and repair; [M] Cell wall/membrane/envelope biogenesis; [O]
Posttranslational modification, protein turnover, chaperones; [P] Inorganic ion transport and metabolism; [Q] Secondary metabolites biosynthesis,
transport and catabolism; [R] General function prediction only; [S] Function unknown; [T] Signal transduction mechanisms; [U] Intracellular trafficking,
secretion, and vesicular transport; [V] Defense mechanisms; [X] No prediction. The ratio for each gene is .1.5 or ,0.66, but .2o r,0.5 in at least one
of the four conditions. The number 2177 represents the total number of amplicons analyzed, covering the entire genome of S. pneumoniae D39. This
number is slightly higher than the number of genes in the genome of D39 (2069), since some amplicons were present in versions for different strains
(i.e. TIGR4, R6, or D39) or in 2 copies.
doi:10.1371/journal.pone.0026707.g001
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fermentation pattern with lactate, formate, acetate and ethanol as
end-products (Fig. 3C). At the time of growth arrest, lactate and
formate accounted each for about 50% of the Gal consumed
(Table 2). Formate, acetate and ethanol were produced in a 2:1:1
ratio, denoting pyruvate formate-lyase activity. This pronounced
shift to mixed acid fermentation in strain D39 might be partially
explained by alleviation of the CcpA-mediated repression of adh,
pfl and pfl-AE during growth on Gal (Table S4). The molecular
mechanism underlying the partial de-repression of the mixed-acid
fermentation genes by CcpA on Gal is not understood.
Unexpectedly, in this carbohydrate inactivation of CcpA resulted
in a more homolactic profile: the yields of formate, acetate and
ethanol decreased, whereas the yield of lactate increased (Fig. 3D,
Table 2). As opposed to Glc-CDM, on Gal the H2O2 produced was
slightly higher in the wild-type (0.3160.02 mM) than in the ccpA
mutant(0.2360.01 mM).Atthetimepointofmaximalbiomass,the
ccpA mutant had consumed 31% of the initial Gal, 5% more than
that consumed by D39. Loss of CcpA did not affect the maximal
Gal consumption rate (Table 2).
Growth and bioenergetic parameters. On Glc, the
amount of biomass (g) formed per mol of substrate consumed or
per mol of ATP (YATP) was higher in the CcpA-deficient strain.
The same trend was observed for cultures growing on Gal: loss of
CcpA resulted in higher biomass yields relative to substrate or
ATP. The lower biomass yields in D39 indicate that,
independently of the carbohydrate, CcpA directs the carbon
source for catabolic processes. Assuming that all ATP is formed by
substrate level phosphorylation, the higher ATP yields in
conditions with higher acetate production were expected
(Table 2). However, the parameters biomass yield and yield on
biomass relative to ATP were lower on Glc than on Gal for both
D39 and the ccpA mutant. These data indicate that Glc is a poorer
substrate than Gal in bioenergetic terms, as more Glc is necessary
to produce similar amounts of pneumococcal biomass.
In brief, when Glc was used as carbon source transcriptome and
metabolic information correlated positively, but on Gal the
fermentation end-products deviated from the predictions based
on transcript levels suggesting regulation at other cellular levels.
CcpA influences the intracellular levels of
phosphorylated metabolites
Inactivation of CcpA renders a strain with altered growth and
fermentation profiles both on Glc and on Gal. In particular, the
disparate substrate consumption rates and the fermentation end-
product patterns, led us to surmise that levels of intracellular
metabolites are also under the influence of CcpA. Intracellular
metabolites were determined in ethanol extracts obtained as for
transcriptome analyses (M and TS phases of growth) by targeted
metabolomics using
31P-NMR (Fig. 4). In this way we were able to
quantify intracellular concentrations of metabolites in central
carbon utilization pathways (carbohydrate-specific pathways, gly-
colysis), catabolic precursors in the synthesis of surface structures
(cell wall, capsule), and co-factors (Fig. 5), detailed below.
Glycolytic and carbohydrate-specific pathway interme-
diates. During growth on Glc the levels of the upper glycolytic
metabolites glucose 6-phosphate (G6P) and FBP were higher in the
ccpA mutant, independently of the phase of growth. Likewise, the
lower glycolytic metabolites 3-phosphoglycerate (3-PGA) and
phosphoenolpyruvate (PEP) accumulated to higher concentrations
in strain D39DccpA. The size of the glycolytic pools showed a
growth phase dependency: the concentrations of G6P, FBP, 3-
PGA and PEP, were smaller in the TS phase. The decrease in the
level of the lower glycolytic metabolites from M to TS phases of
growth was unexpected and is contrary to the accumulation profile
of 3-PGA and PEP in other Streptococcaceae species [19,20],
suggesting different regulation at the level of pyruvate kinase in
S. pneumoniae. The concentrations of the glycolytic intermediates
were also lower in the TS phase of growth when Gal was used as
sole carbon source. In contrast to Glc, loss of CcpA on Gal
resulted in slightly lower glycolytic pool levels. Furthermore, D39
and D39DccpA cells growing on Gal accumulated tagatose 1,6-
bisphosphate (TBP), a-galactose 1-phosphate (a-Gal1P) and a-
glucose 1-phosphate (a-G1P), denoting simultaneous
dissimilation of Gal via the tagatose 6-phosphate and Leloir
pathways (Fig. 4 and 5). While deletion of ccpA had only a
moderate negative effect on the accumulation of the Leloir
Figure 2. Visual representation of the effect of CcpA on the
transcription of genes involved in key basic metabolic
processes. Ratio’s of genes in glycolysis, the Leloir and tagatose 6-
phosphate pathways, and the pyruvate node, in all four conditions
analysed in this study (Glc_M, Gal_M, Glc_TS, Gal_TS) are depicted. On
top of the figure, a colour scale is given for the ratio of the expression in
the ccpA mutant over that in the wild-type strain. Thus, red means
repression by CcpA (upregulation in the microarray analysis) and green
means activation by CcpA (downregulation in the microarray analysis).
For each gene the D39 locus tag and the gene name is given on the
right. No cut-off value was applied for the expression ratios of the genes
given in the figure. Genes were considered significantly changed when
having a Bayesian p-value and FDR meeting the criteria as outlined in
the Materials & Methods. Genes that did not meet these criteria were
given a ratio of 1.0 (black colour), meaning no significant change in
expression. See Fig. 5 for an overview of these pathways in S.
pneumoniae D39.
doi:10.1371/journal.pone.0026707.g002
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was 10-fold lower in D39DccpA. This striking difference might be
a direct consequence of the higher lac transcript levels in D39
(Table S1 and S4), since the overall Gal consumption flux was
identical in both strains (Table 2). It should be noted that TBP
and a-Gal1P are not detected during growth on Glc, whereas a-
G1P, which is also the key precursor of structural polysaccharides
(eg. capsule, teichoic acids) accumulated exclusively in the ccpA
mutant.
NDP-activated intermediates in the synthesis of surface
structures. NDP-activated intermediates are soluble precursors
in the synthesis of several cell surface structures of utmost
importance for virulence and pathogenesis [1,2]. During growth
on Glc, UDP-glucose, a precursor in the biosynthesis of the serotype
2 capsule and other structural polysaccharides, showed growth
dependent accumulation in both strains, but the reduction from M
to TS was more pronounced in the ccpA mutant. Furthermore, the
accumulation profile of the soluble cell wall precursor UDP-N-
acetylglucosamine was not changed due to inactivation of ccpA,
whereastheconcentrationofUDP-N-acetylmuramoyl-pentapeptide
was higher in D39DccpA. Curiously, on Gal the soluble cell wall
components were below detection limits (,0.5 mM), except for
UDP-N-acetylglucosamine, which accumulated in S. pneumoniae D39
in MS growth. Accumulation of CDP-choline, the phospho-
rylcholine donor in the synthesis of teichoic acids, was higher in
the ccpA mutant, decreasing in both strains from M to TS phases
during growth on Glc. The growth dependent behaviour was also
observed on Gal, but in this carbohydrate the levels of CDP-choline
were approximately the same in D39 and D39DccpA.
Concentrations of metabolic cofactors. CcpA-defective
cells growing on Glc accumulated slightly higher amounts of
NAD
+, identical levels of CTP and ADP, and circa 2-fold higher
amounts of ATP in MS growth (Fig. 4). In the TS phase of growth
NAD
+ and ATP were not significantly affected, ADP was slightly
lower, and CTP was about half the concentration in the ccpA
mutant. When Gal was used as substrate, the accumulated levels of
NAD
+, CTP, ATP and ADP were lower in the ccpA mutant both
in M and TS phases of growth.
Figure 3. Fermentation profiles of D39 and D39DccpA on Glc and Gal. Growth curves, substrate consumption and end-products formed by
the D39 (A and C) and D39DccpA (B and D) strains growing on Glc (A and B) or Gal (C and D). Culture supernatant samples for substrate and end
product analysis by HPLC and/or
1H-NMR were harvested for each of the conditions in the mid-exponential, transition-to-stationary and growth arrest
(maximal biomass) time points of the respective growth curves (bars in the plots). To calculate end-product concentrations, values of at least two
independent experiments were averaged and the error was below 7% for major products (.2 mM) and 25% for minor products (,2 mM). Initial
concentrations of Glc and Gal were 5661 mM and 5761 mM, respectively. Time points in substrate consumption curves are averages of at least two
independent experiments and the error is below 5%. Symbols: (#), substrate consumption; (&), growth curve; white bars, lactate; hatched bars,
formate; black bars, acetate; stripped bars, ethanol. Growth curves as in Fig. S1, except that OD600 scale (y-axis) is decimal.
doi:10.1371/journal.pone.0026707.g003
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operation of two routes for Gal catabolism and suggest a unique
mechanism underlying the regulation of glycolysis in S. pneumoniae.
CcpA influences the level of key phosphorylated metabolites
(glycolytic metabolites, co-factors, etc) potentially involved in
metabolic regulation. These findings extend beyond transcription-
al regulation the role of CcpA in controlling cellular network
properties. Furthermore, CcpA-dependent changes in cell wall
and capsule UDP-activated precursors indicates a role of CcpA in
the modulation of cell surface properties, known to be critical in
virulence and pathogenesis.
CcpA inactivation loosens capsule attachment to the cell
wall
It has previously been reported that CcpA-deficient mutants
show attenuated virulence, and this behaviour was associated with
lower expression of genes committed to the synthesis of the
pneumococcal capsule [11]. Our metabolome data showed
significant differences in the pools of the capsule cytoplasmic
precursors UDP-glucose and a-G1P. Therefore, we deemed it
important to measure the amounts of capsule produced in D39 and
its ccpA mutant (Fig. 6). Curiously, inactivation of ccpA did not affect
the total amount of capsule either on Glc- or Gal-CDM. However,
Figure 4. Effect of ccpA deletion on intracellular concentrations of phosphorylated metabolites during growth on Glc or Gal.
Phosphorylated metabolites were measured by
31P-NMR in ethanol extracts of S. pneumoniae D39 and DccpA strains grown to mid-exponential (M,
white bars, OD600 of 0.3560.02) or transition-to-stationary phases (TS, black bars, OD600 of 1.360.1) of growth in CDM supplemented with 5661m M
Glc (white background) or 5761 mM Gal (light grey background). Phosphorylated metabolites measured in extracts comprised glycolytic
metabolites, phosphorylated carbohydrate-specific metabolites, UDP-activated metabolites, and co-factors. The values are the mean of three
independent experiments 6 SD.
doi:10.1371/journal.pone.0026707.g004
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higher for both strains. Furthermore, a major difference in Gal-
CDMwastheamountofloosecapsule(notattached tothe cellwall),
which accounted for about 94% of the total polysaccharide in
D39DccpA (Fig. 6).In the parent strain,only a small fraction (,13%)
of loose capsule was detected, exclusively in the TS phase of growth.
Although the role of CcpA in the regulation of capsule
production was not confirmed, our data show a function of CcpA
in the association of capsule to the cell wall, at least during growth
on Gal.
CcpA affects the expression of many virulence genes
To further identify links between CcpA and virulence we
compared all genes that have been linked to the virulence of this
pathogen with our list of genes influenced by deletion of ccpA
(Table S7). In addition, the ccpA microarray data were compared
Figure 5. Schematic representation of central metabolic pathways in S. pneumoniae D39. Glc is oxidized to pyruvate via the Embden-
Meyerhof-Parnas pathway (Glycolysis, orange box). Homolactic fermentation reduces pyruvate into lactate, whereas mixed-acid fermentation leadst o
other products, such as formate, acetate and ethanol (Pyruvate metabolism, yellow box). Gal is converted to G6P by the Leloir pathway (light pink
box) and to dihydroxyacetone phosphate or glyceraldehyde 3-phosphate by the tagatose 6-phosphate pathway (light orange box). Pathways for
capsule, peptidoglycan and phosphorylcholine biosynthesis are shown in light blue, light purple and light green boxes, respectively. Putative and
functional characterized genes encoding depicted metabolic steps are shown in white boxes. Proposed pathways were reconstructed based on
genome information (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi), literature and database surveys (KEGG, MetaCyc). Gene annotation
downloaded from NCBI: galM, aldose 1-epimerase; galK, galactokinase; galE-1, UDP-glucose 4-epimerase; galT-2, galactose 1-phosphate
uridylyltransferase; pgm, phosphoglucomutase/phosphomannomutase family protein; galU, UTP-glucose 1-phosphate uridylyltransferase; cps2L,
glucose 1-phosphate thymidylyltransferase; cps2K, UDP-glucose 6-dehydrogenase, putative; rfbC, dTDP-4-dehydrorhamnose 3,5-epimerase, putative;
rfbB, dTDP-glucose 4,6-dehydratase; rfbD, dTDP-4-dehydrorhamnose reductase; gki, glucokinase; pgi, glucose 6-phosphate isomerase; pfkA,6 -
phosphofructokinase; fba, fructose bisphosphate aldolase; tpiA, triosephosphate isomerase; gap, glyceraldehyde-3-phosphate dehydrogenase; pgk,
phosphogltcerate kinase; gpmA, phosphoglyceromutase; eno, phosphopyruvate hydratase; pyk, pyruvate kinase; lacA, galactose 6-phosphate
isomerase subunit LacA; lacB, galactose 6-phosphate isomerase subunit LacB; lacC, tagatose 6-phosphate kinase; lacD, tagatose 1,6-diphosphate
aldolase; ldh, L-lactate dehydrogenase; lctO, lactate oxidase; spxB, pyruvate oxidase; ackA, acetate kinase; pta, phosphotransacetylase; pfl, pyruvate
formate-lyase; adh (spd_1834), bifunctional acetaldehyde-CoA/alcohol dehydrogenase; glmS, D-fructose 6-phosphate amidotransferase; glmU, UDP-
N-acetylglucosamine pyrophosphorylase; murA-1 and murA-2, UDP-N-acetylglucosamine 1-carboxyvinyltransferase; murB, UDP-N-acetylenolpyr-
uvoylglucosamine reductase; murC, UDP-N-acetylmuramate-L-alanine ligase; murD, UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase; murE,
UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase; murF, UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate–D-
alanyl-D-alanyl ligase; tarJ (spd_1126), alcohol dehydrogenase, zinc-containing or TarJ; tarI (spd_1127), 2-C-methyl-D-erythritol 4-phosphate
cytidylyltransferase or TarI; licB, protein LicB; pck, choline kinase or LicA; licC, CTP:phosphocholine cytidylyltransferase; LicD1, phosphotransferase
LicD1; LicD2, phosphotransferase LicD2.
doi:10.1371/journal.pone.0026707.g005
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Hava and Camilli [21]. Virulence genes affected by CcpA
included classical virulence factors as well as many genes involved
in amino acid and carbohydrate metabolism, transcriptional
regulators, and genes with unknown function (Table S7).
Of the classical virulence factors, the Mn
2+-dependent super-
oxide dismutase gene sodA, involved in virulence and protection
against oxidative stress [22], was upregulated in the ccpA mutant,
which fits well with lower H2O2 concentrations observed in this
strain. Interestingly, two of the three neuraminidase genes, namely
nanA and nanB, which have been extensively studied regarding
their important role in pneumococcal virulence [15], were strongly
upregulated in the ccpA mutant in all four conditions as well.
Recently, NanA had been shown to, in conjunction with BgaA and
StrH, two other exoglycosidases, protect S. pneumoniae from
phagocytic killing through prevention of complement deposition
[23]. StrH was affected only slightly in Glc_TS and Gal_TS, but
bgaA was, like nanA and nanB, upregulated in the ccpA mutant in all
four conditions, most strongly on Glc; importantly, bgaA was
repressed in Glc compared to Gal (Table S4) only in the wild-type,
which further supports its role in nasopharyngeal colonization. All
these three genes, as well as nanB, might be directly affected by
CcpA, since there is a predicted cre site in their upstream region or
in the upstream region of a gene with which they seem to be co-
regulated in the array analyses. Of a total of 79 virulence genes of
which transcription is affected in the ccpA mutant, 35 are possibly
regulated directly by CcpA (Table S7).
The pcpA gene, implicated in colonization/infection of the
airways [24], showed glucose-dependent CcpA-mediated repres-
sion in D39. The pcpA gene is also regulated depending on the
extracellular concentration of Mn
2+ and Zn
2+ through the action
of PsaR [25], and activated by the nutritional regulator CodY
[26]. It therefore seems to be regulated in a complex way in
response to various different environmental stimuli.
Interestingly, genes involved in choline metabolism, namely the
licABC and tarJI operons were upregulated in the ccpA mutant
especially in Glc_TS. In agreement, the levels of CDP-choline
were higher in the ccpA mutant (Fig. 4). Together the data suggest
that ccpA could affect the level of choline in the pneumococcal cell
wall and as a result the decoration of the pneumococcal cell wall
with choline binding proteins, a class of virulence factors.
An interesting observation, which might be associated with
virulence, was the strong activation by CcpA of two genes involved
in cell wall synthesis (glmS and murF) only during growth on
glucose. Moreover, the increased transcript level of glmS and murF
in D39 on glucose might correlate with the high demand for
synthesis of biomass as denoted by the high growth rate in this
condition.
Of the transcriptional regulators identified as virulence genes,
comDE was downregulated on Glc, whereas TCS07 was upregu-
lated in all conditions, which suggests that their regulons and their
respective stimuli are connected to that of CcpA.
With a few exceptions, CcpA acts as a repressor of virulence
gene expression in S. pneumoniae. Based on our data it is reasonable
to assume that CcpA is one of the factors controlling the
interaction of S. pneumoniae with its host during colonization and
infection of the airways through regulation of the above mentioned
key virulence genes.
Discussion
It is well established that bacteria adapt to fluctuating
environments by altering expression of genes involved in basic
metabolic processes. In the Firmicutes, the pleiotropic transcrip-
tional regulator CcpA is recognized as a key player in carbon
catabolite control, i.e., the regulatory phenomena that allow
bacteria to selectively use substrates for growth (for reviews see
[3,4]). Importantly, in the last decade an increasing number of
studies have exposed the role of CcpA in the regulation of
virulence in Gram-positive pathogens [7,10,11,27–29]. In the
human pathogen S. pneumoniae, regulation of carbohydrate-specific
catabolic pathways as well as modulation of virulence factors by
CcpA has been reported [10–12]. However, a comprehensive
study of the role of CcpA in the physiology of S. pneumoniae was not
undertaken so far. In a recent study, ccpA was found to interact
with 64 other genes by Tn-seq transposon mutagenesis; based on
the high number of genetic interactions these authors suggested
that CcpA appears to be a master regulator in S. pneumoniae [30].
In this work, we used genome-wide transcriptome analyses and
metabolite profiling to study in depth the impact of CcpA on
pneumococcal metabolism and virulence. Our data show that
beyond controlling carbohydrate transport and metabolic genes,
CcpA is involved in various other cellular processes, including
traits connected to virulence and pathogenesis (Fig. 7). Therefore,
the role of CcpA as a master regulator in S. pneumoniae is
undoubtedly demonstrated by the results in this study.
The CcpA regulon was substantial on Glc, the ‘‘preferred’’
carbohydrate of many Firmicutes, which supports high pneumo-
coccal growth rate (Fig. 3), but remarkably this was also the case in
the slowly metabolized Gal, a carbohydrate generally recognized
as non-repressing. In B. subtilis, besides Glc several other PTS-
transported carbohydrates are capable of eliciting CcpA-mediated
catabolite repression [31]. In S. mutans, the transport of Gal is
exclusively mediated via PTS systems [9], but curiously the CcpA
regulon on Gal was markedly smaller than on Glc [7], which is in
contrast to our observations in S. pneumoniae. Also noticeable is the
pronounced difference in the amount of genes influenced by CcpA
in S. mutans (up to 9%) and S. pneumoniae (up to 19%), which despite
their genetic relatedness apparently have evolved distinct regula-
tory networks. In S. mutants, catabolite repression can be
Figure 6. Amount of capsule polysaccharide in D39 and its
isogenic ccpA mutant. Estimation of capsule was performed based
on the determination of its glucuronic acid content in strains D39 and
D39DccpA in mid-exponential (white bars, OD600 of 0.3560.02) and
transition-to-stationary (black bars, OD600 of 1.360.1) cultures grown in
CDM containing 5661 mM Glc (white background) or 5761 mM Gal
(light grey background). Hatched bars indicate loose capsule polysac-
charide. All the determinations were done twice in two independent
cultures and the values are means 6 SD.
doi:10.1371/journal.pone.0026707.g006
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carbohydrate-PTS permeases [9]. A reasonable explanation lies
in the nutritional diversity encountered by the two streptococci in
their respective ecological niches.
In this study, CcpA ensures fast growth on Glc, but not on Gal,
as the growth rate on the latter carbohydrate is basically
independent of this pleiotropic regulator. In S. pneumoniae the
routes for Gal catabolism have not been biochemically character-
ized, but complete Leloir and tagatose 6-phosphate pathways can
be deduced from pneumococcal genome sequence data (http://
www.ncbi.nlm.nih.gov/genome/lproks.cgi). We propose that both
pathways are operative during growth on Gal. The presence of the
intermediates a-Gal1P (Leloir) and TBP (tagatose 6-phosphate), as
well as the elevated expression levels of the genes galM, galKT-2
(Leloir), and lacABCD (tagatose 6-phosphate), fully support this
claim. Interestingly, lacFE are also induced by Gal, suggesting a
role of the pneumococcal lactose-PTS in Gal uptake as reported
for S. mutans and L. lactis [9,32]. The uptake of Gal via a PTS
system would ensure a typical PTS-mediated signal transduction
pathway for CcpA regulation and is in agreement with the large
CcpA regulon determined during growth on Gal. On this
carbohydrate, CcpA regulation seems to comply with the essence
of catabolite control, which is to coordinate metabolic operation
ensuring a maximum profit for growth. Activation by CcpA of the
PTS-dependent route (tagatose 6-phosphate pathway) for Gal
degradation, while repressing the Leloir genes, is in agreement
with that principle. Furthermore, activation of the glycolytic genes
pfk and pyk, and ldh indicate that CcpA’s role is to enable maximal
Gal catabolism. In light of our results, an answer to the question as
to why substrate consumption and growth rates on Gal are not
stimulated by CcpA is difficult to put forward. Of note in Gal-
grown D39 cells, is the elevated concentration of TBP (10-fold
higher than in D39DccpA), which might be toxic for the cells.
Indeed, unrestricted accumulation of phosphorylated metabolites
has previously been evoked to explain negative effects on growth
rate [33,34]. Also surprising was the pronounced shift to mixed
Figure 7. Model for CcpA regulation of basic metabolic processes and virulence factor expression in the presence of Glc or Gal in S.
pneumoniae. Transport of carbohydrates through the multi-protein phosphoenolpyruvate phosphotransferase system (PTS) ensures a typical PTS-
mediated signal transduction pathway for CcpA regulation. CcpA-mediated regulation results in altered expression of genes involved in carbohydrate
metabolism and classical virulence factors, including cell wall associated proteins, transcriptional regulators and phosphorylcholine. Repression and
activation are represented by red and green arrows, respectively. Dashed lines indicate metabolic regulation. G6P, Glucose 6-phosphate; F6P, fructose
6-phosphate; CW, cell wall; MA, mixed-acid fermentation; PcpA, choline binding protein PcpA; BgaA, beta-galactosidaseA; NanAB, neuraminidases A
and B; PCho, Phosphorylcholine; SodA, superoxide dismutase, manganese-dependent; StrH, b-N-acetylhexosaminidase; TCS07 and ComDE, two-
component systems.
doi:10.1371/journal.pone.0026707.g007
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involved in that type of metabolism. However, Gal-induced
alleviation of the CcpA-mediated repression might partially
explain the observed behaviour (Table S1). Indeed, higher
expression of pfl and pfl-AE allow a more efficient competition
with lactate dehydrogenase for the common substrate pyruvate,
consequently increasing the flux to mixed acid products, including
acetate. Production of this organic acid is accompanied by ATP
formation, which is certainly an advantage during the fermenta-
tion of Gal, as the glycolytic ATP generation is limited by the
substrate consumption rate (three times lower than that of Glc).
Shifts to mixed acid fermentation as a means to counteract for
ATP production during growth on slowly metabolized carbon
sources or limiting carbohydrate concentrations carbohydrates are
well documented in Streptococacceae [35,36]. In view of the data it is
reasonable to assume that Gal-dependent regulatory mechanisms
at the translational, posttranslational and/or metabolic levels
overlay the transcriptional direct control by CcpA. A good
example is the Gal-dependent activation of the Leloir pathway,
which genes are in all instances under CcpA repression. The lack
of correlation between phenotypic behaviours and changes in
transcription levels is not unprecedented [37,38], and most likely
derives from the feedback regulation of metabolism on all
regulatory layers [13].
In this work we show that CcpA is crucial in the control of central
physiological processes in S. pneumoniae, and thus most likely
influences the ability to persist and proliferate in the host.
Considering our data showing Glc- and Gal-dependent regulation
it is tempting to hypothesize that in the specific host microenviron-
ments basic metabolic processes are tuned by CcpA to maximize
cellular profit (Fig. 7). In this light, the attenuated virulence shown
byccpA mutantsinmousemodels ofpneumococcalcolonizationand
infection [10,11] can plausibly be attributed to decreased fitness.
However, this hypothesis might not depict the full picture, as we
discovered that CcpA directly or indirectly influences the transcript
level of a number of canonical virulence factors (Fig. 7). It is
interesting to note that among the influenced genes several encode
moonlighting proteins, with roles in host-pathogen interaction and
basic metabolic processes. A good example is provided by BgaA, an
exoglycosidase involved in adherence to epithelial cells [15], and
recently found to be important in basal growth [30], which is
repressed by CcpA as determined by us and others [10,12]. Such
findings certainly reinforce the subtle link between basic physiology
and virulence in S. pneumoniae.
Involvement of CcpA in the control of classical virulence factors is
a recurrent observation in Streptococacceae[7,8,10,11,30]. In a previous
report, significant repression of the capsular polysaccharide biosyn-
thesis locus (cps) was observed in a pneumococcal ccpA mutant [11].
Except for a negligible effect on rfbCBD genes in the transition-to-
stationary phase of Glc-grown cells, we have not found significantly
differentially expressed cps genes in any other tested conditions.
Furthermore, the amount of capsule produced was not influenced by
CcpA (Fig.6).Accordingly, Camilli and co-workersdid not observe a
connection between CcpA and cps expression [10,30]. Our data
unequivocally show that the production of capsule is influenced by
the carbon source, since the amount of polysaccharide was doubled
in Gal-grown cells in a CcpA-independent manner. In view that Gal
is a prevailing carbohydrate in nasopharyngeal secretions [15,39],
this finding is relevant in terms of host-pathogen interactions, since a
relatively thick capsule is essential to evade the immune system, and
thus, for the pneumococcus to persist in the host [40]. Curiously, on
this carbohydrate the attachment of the capsular polysaccharide to
the pneumococcal cell wall was substantially altered in the presence
of CcpA.
Our transcriptome analyses revealed that genes involved in the
synthesis of phosphorylcholine are under the control of CcpA. At
the metabolic level, the lower concentration of CDP-choline
(activated choline precursor) is in full agreement with the
transcript levels of the biosynthetic genes. The tight control
exerted by CcpA on the availability of CDP-choline might provide
a means to influence the association of capsule, proteins and other
molecules to the cell wall. Indeed, binding of macromolecules to
the cell wall is conditioned by the decoration of the wall
polysaccharides (teichoic acids and lipoteichoic acids) [41,42],
which in S. pneumoniae contain residues of phosphorylcholine [42].
Using proteomics others have shown that loss of CcpA caused
changes in the amounts of several cell wall-associated proteins
[10]. A good correlation between our expression data and the wall
fraction protein levels was observed for some proteins [10], but for
other proteins no significant regulation at the transcriptional level
was detected. Although we cannot rule out the possibility that this
is due to interspecies variation or translational and post-translation
regulation, in light of our results it is reasonable to speculate that,
rather than altering the protein level, CcpA is somehow affecting
the tethering of the proteins to the cell wall, as we showed for
capsule attachment. CcpA-dependent effects on the levels of
several NDP-activated precursors of wall polysaccharides (Fig. 4)
further strengthen the role of CcpA in shaping the cell wall
decoration. This unforeseen function of CcpA might be crucial in
the host-pneumococcal interaction, which is heavily dependent on
cell wall phosphorylcholine and associated proteins [2]. Future
studies on cell-surface proteome should be performed to address
this issue in more detail.
Of the promoters differentially regulated in the ccpA mutant circa
42% are presumably subject to direct regulation by CcpA, as
denoted by the presence of a cre sequence. This value is in good
agreement with the 38% previously determined using the Tn-seq
method to evaluate genetic interactions [30]. Still, a large
percentage of the regulated promoters lack a canonical cre site.
CcpA influenced the transcript level of 22 other transcriptional
regulators, and thereby indirectly affects genes that are under the
control of these regulators. Interestingly, we found that CcpA-
responsive genes are also part of other regulatory networks. About
15 genes, mainly involved in amino acid and carbohydrate
metabolism, but also the virulence gene pcpA, are commonly
regulated by the nutritional regulator CodY and CcpA [26].
Additionally, CcpA was found to share many gene targets with two-
component systems regulatory networks, including those of CiaRH
[43], TCS04 [44], TCS06 [45], TCS08 [46], and TCS09 [47].
Recent studies in S. pyogenes have highlighted the importance of a
combination ofindependenttranscriptionalregulatorstocoordinate
gene expression during infection [28,48]. In this light, our data
opens new avenues to explore how S. pneumoniae virulence is shaped
by co-regulation of independent transcriptional regulators.
Factors controlling the interaction between pathogens and their
host are of utmost importance for in vivo fitness and persistence in
adverse host niches. Previously, the role of the transcriptional
regulator CcpA in the physiology of the pneumococcus has been
underappreciated. In this work we resorted to a combined
transcriptome and metabolite profiling approach to demonstrate
that CcpA is a master regulator involved in varied cellular
processes in S. pneumoniae. We have ascertained that S. pneumoniae
optimizes basic metabolic processes, modulates expression of
virulence factors and most likely tunes association of macromol-
ecules with the cell wall in a CcpA-mediated manner. The
observed carbohydrate-dependency of the CcpA regulatory
network indicates a key role in adjusting to specific nutritional
cues within host niches. Exploring the unveiled links between
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improved understanding on the ability of S. pneumoniae to colonize
and cause disease. The insights gained thus far from this
comprehensive analysis foresee CcpA as a key factor in the
interaction between S. pneumoniae and its host.
Materials and Methods
Bacterial strains, media and growth conditions
Strains and plasmids used in this study are shown in Table 1. S.
pneumoniae strains were grown as standing cultures without aeration
in M17 broth (Difco
TM) containing Glc 0.5% (w/v) or on Glc-
M17 (0.5% w/v) agar plates with 1% (v/v) defibrinated sheep
blood (Johnny Rottier) at 37uC. When appropriate 150 mgm l
21
spectinomycin, 2.5 mgm l
21 chloramphenicol, 0.25 mgm l
21
erythromycin or 15 mgm l
21 trimethoprim were added to the
medium. Capsule quantification, transcriptomic and metabolic
experiments were performed with cells grown in chemically
defined medium (CDM) [19], supplemented with disodium b-
glycerophosphate (21 g L
21), sodium pyruvate (0.01% w/v),
choline (0.001% w/v) and cysteine (0.4 g L
21) in static flasks at
37uC without pH control (initial pH 6.5). Glc (5661 mM) or Gal
(5761 mM) was used as the carbon source. For complementation
studies, nisin was added at time zero. Growth of the cultures was
monitored by measuring optical density at 600 nm every hour.
Maximum specific growth rates (mmax) were calculated through
linear regressions of the plots of ln (OD600) versus time during the
exponential growth phase.
Molecular techniques
Chromosomal DNA isolation was performed according to the
procedure of Johansen and Kibenich [49]. Plasmid isolation was
carried out using the plasmid isolation kit from Roche. Phusion
DNA polymerase (Roche), T4 DNA ligase (Roche) and restriction
enzymes (Fermentas) were used according to the recommenda-
tions described by the suppliers. Purification of the PCR products
was performed using the High pure PCR product purification kit
from Roche. Purified PCR products or recombinant plasmids
were introduced into S. pneumoniae by transformation as described
in Kloosterman et al. [50]. Positive transformants were selected on
Glc-M17 agar with the appropriate antibiotic and confirmed by
PCR and sequencing. L. lactis MG1363 was transformed with
plasmid DNA by electroporation according to Holo and Nes [51].
Construction of a ccpA mutant of S. pneumoniae D39
Oligonucleotide primers used in this study are listed in Table 1.
In S. pneumoniae D39, ccpA forms a monocistronic operon, flanked
upstream by a well defined promoter region and downstream by a
strong terminator (predicted DGu=213.8 kcal mol
21). The ccpA
deletion was accomplished by allelic replacement mutagenesis as
follows: the up- (547 bp) and downstream (517 bp) regions of the
ccpA gene (1010 bp) were PCR-amplified from D39 chromosomal
DNA using the primer pairs ccpA_D39_KO-1/ccpA_D39_KO-2
(spec) and ccpA_D39_KO-3 (spec)/ccpA_D39_KO-4, respective-
ly. The resulting PCR products were, by means of overlap
extension PCR [52], fused to a Spc
R gene (1032 bp, amplified with
primers Spec_Fp and Spec_Rp from plasmid pORI38) using the
primers ccpA_D39_KO-1 and ccpA_D39_KO-4. The DccpA::spc
PCR product (2096 bp) obtained in this way was transformed to S.
pneumoniae D39, giving rise to the ccpA deletion mutant (D39DccpA
in Table 1). Replacement of the ccpA gene with the spc gene and
correct integration of the insert were confirmed by PCR and
sequencing (Service XS). To rule out the possibility of suppressor
mutations arising with the deletion of ccpA, the transformation
efficiency of the DccpA::spc PCR product was compared with that
of the SPD_0786::spc (SPD_0786 insertion-deletion) PCR product.
SPD_0786 is a non-essential transcription factor, which disruption
does not affect growth of S. pneumoniae in CDM (Kloosterman et al.,
unpublished results). A similar number of transformants per ng of
DNA (CFU ng
21) was obtained, strongly suggesting that our ccpA
strain contains no suppressor mutations.
Transformation frequency assay
For the transformation frequency assay the 2096-bp fragment
comprising the DccpA::spc region was PCR-amplified from the
chromosomal DNA of the ccpA mutant strain using the primer
pairs ccpA_D39_KO_1 and ccpA_D39_KO_4. Similarly, a
fragment (2725-bp) encompassing the SPD_0786::spc region of a
D39 SPD_0786::spc strain was amplified using appropriate primer
pairs. An identical concentration of each product was used to
transform strain D39 as described above. Spectinomycin resistant
colonies were selected and counted for each transformation and
the number of colonies was compared to evaluate the transfor-
mation frequency.
Construction of the ccpA complementation strain
A ccpA complementation strain was constructed using the NICE
system improved for S. pneumoniae [50]. In this arrangement the
NisRK two-component system, coded by the nisRK genes, activate
the expression of the nisA promoter in the presence of nisin. The
procedure to construct the ccpA complementation strain is
described as follows. The ccpA mutant strain (D39DccpA) was
transformed with chromosomal DNA from D39nisRK, a stable
derivative of S. pneumoniae D39 that harbours the nisRK genes and a
Trim
R gene in the bgaA locus. Trimethoprim resistant clones
(D39DccpAnisRK in Table 1) were selected and the presence of both
the ccpA deletion and the nisRK genes was confirmed by PCR. For
the construction of the plasmid harbouring ccpA under the control
of the nisin-indusible promoter nisA (pNZ[ccpA] in Table 1), the
ccpA gene was PCR-amplified from D39 chromosomal DNA using
the primers ccpA_D39-1 and ccpA_D39-2 and cloned as a BsaI/
XbaI fragment in NcoI/XbaI digested pNG8048E. L. lactis MG1363
was used as the cloning host. The ccpA complementation strain
(D39DccpAnisRKpNZ[ccpA] in Table 1) was constructed by
transformation of the D39DccpAnisRK strain with plasmid
pNZ[ccpA] selecting for chloramphenicol resistant clones. As a
control D39DccpAnisRK strain was also transformed with the empty
plasmid pNZ8048. Strains were confirmed by PCR.
Transcriptome analysis
S. pneumoniae D39 and the isogenic ccpA mutant were compared
by transcriptome analysis using whole-genome S. pneumoniae DNA
microarrays, representing all TIGR4 ORFs, as well as R6 and
D39 ORFs that are not in TIGR4 [53]. See http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GPL11484, for a description
of all amplicons and oligo’s present on the DNA microarray. The
two strains were grown as described above in three biologically
independent experiments and harvested at mid-exponential
(OD600 of 0.3560.02) and transition-to-stationary (OD600 of
1.360.1) phases of growth (Fig. S1). mRNA isolation, synthesis of
cDNA, labelling of cDNA, hybridization, scanning of the slides
and the processing and analysis of the data was carried out as
described before [53]. Genes were considered to have significantly
altered expression when the bayesian p-value was ,0.001, the false
discovery rate (FDR) was ,0.01 and the ratio (signal DccpA/signal
D39) was .1.5 or ,0.66, but .2o r,0.5 in at least one of the
four conditions. For the Gal_TS comparison, data were derived
from two independent hybridizations and a Bayesian p-value
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this way, also an in silico comparison was done between Glc and
Gal, both for the M and TS phases and also in both D39 wild type
as well as DccpA. To this end, raw signals (i.e. slide images) of the
Glc experiments were compared with the corresponding signals of
the Gal experiments and analyzed as described above. The
microarray data have been deposited at GEO under accession
number GSE31819.
Cre site prediction
Using the L. lactis consensus sequence (WGWAARC-
GYTWWMA, [6], a cre site prediction was performed in D39,
using Genome2D [17]. Subsequently, genes with a cre site in their
promoter region that were differentially expressed in the DNA
microarray analyses of the ccpA mutant were used to built a weight
matrix, which was subsequently used to search the genome again
using Genome2D [17], using a cut-off score of 9.9. In a similar
way, the weight matrix of the RegPrecise (http://regprecise.lbl.
gov/RegPrecise/) prediction was used. The resulting predictions
(Table S6) were compiled together with the original prediction of
RegPrecise and a prediction done in a recent publication [30].
The resulting list of 340 genes with putative cre sites was compared
with the genes that were differentially expressed in the arrays. Of
these 340 genes with cre sites, 115 matched with the list of genes
differentially expressed in the ccpA mutant in at least one condition.
After re-analysis of these matches with an online cre site prediction
tool (http://molgen51.biol.rug.nl/websoftware/ppp/ppp_start.
php), 90 genes were left that contain a putative cre site in their
promoter region, or downstream of the translational start.
Real-time quantitative RT-PCR
Cell samples obtained as described above for transcriptome
analyses using DNA microarrays were treated with RNase-free
DNase I (Fermentas, St. Leon-Rot,Germany) for 60 minat 37uCi n
DNaseI buffer (10 mmol l
21 Tris-HCl (pH 7.5), 2.5 mmol l
21
MgCl2, 0.1 mmol l
21 CaCl2). Samples were purified with the
Roche RNA isolation kit. Reverse transcription was performed on
5 mg of total RNA using the same method as used during the
microarray procedure. Quantification of specific cDNA of
spd_0420 (pfl), spd_0667 (sodA), spd_0790 (pyk), spd_1053 (lacE),
spd_1078 (ldh), spd_1504 (nanA) and spd_1634 (galK) was performed
on an CFX96 Real-Time PCR System (BioRad, Hercules, CA)
using Maxima SYBR Green qPCR Master Mix (Fermentas, St.
Leon-Rot, Germany) on 5 ng cDNA template in a 20 ml reaction
volume. Primers used are listed in Table 1. The qRT-PCR data
were normalized to the level of metG (spd_0689) cDNA using the
2
2DDC
T method [54]. The data are averages of four repeats.
Quantification of fermentation products during growth
Strains were grown as described above. Culture samples (2 ml)
weretakeninmid-exponentialandtransition-to-stationaryphasesof
growth, centrifuged (16,0006g,2m i n ,4 uC), filtered (Millex-GN
0,22 mm filters) and the supernatant solutions were stored at 220uC
until analysis by high performance liquid chromatography (HPLC).
Prior to analysis, samples were allowed to thaw at room
temperature. Glc or Gal and end-products were quantified in an
HPLC apparatus equipped with a refractive index detector (Shodex
RI-101, Showa Denko K. K.) using an HPX-87H anion exchange
column (Bio-Rad Laboratories Inc.) at 60uC, with 5 mM H2SO4 as
the elution fluid and a flow rate of 0.5 ml min
21. Alternatively,
quantification of metabolites in the supernatant solutions was
performed by
1H-NMR in a Bruker Avance II 500 MHz
spectrometer (Bruker BioSpin GmbH). Formic acid (sodium salt)
was added to the samples and used as an internal concentration
standard. The ATP yield was calculated as the ratio of ATP
produced to Glc or Gal consumed. The global yields of ATP were
calculated from the fermentation products determined at the time-
point of growth arrest assuming that all ATP was synthesized by
substrate-level phosphorylation. A factor of 0.39, determined from a
DW (mg ml
21) versus OD600 curve, was used to convert OD600 into
dry weight (mg biomass ml
21).Hydrogen peroxide was quantified in
fresh supernatant solutions using the AmplexH Red hydrogen
Peroxide/Peroxidase assay kit from Invitrogen.
Determination of hydrogen peroxide (H2O2)
Strains were grown in chemically defined medium (CDM) as
described above. Culture samples of 1-ml were harvested in mid-
exponential and transition-to-stationary phases of growth, centri-
fuged (16,0006g, 2 min, 4uC) and filtered (Millex-GN 0,2 mm
filters). The AmplexH Red hydrogen Peroxide/Peroxidase assay
kit from Invitrogen was used to quantify the hydrogen peroxide
contents in the fresh supernatant solutions.
Cold ethanol extractions and determination of
intracellular metabolites by
31P-NMR
The ethanol extracts were prepared as described previously by
Ramos et al. [55]. For each extract the volume of cells harvested
from mid-exponential (OD600 of 0.3560.02) and transition-to-
stationary (OD600 of 1.360.1) cultures corresponded to approxi-
mately 14 mg of protein and the centrifugation was performed at
4uC, 6,0006g, during 3 min. The dried extract was dissolved in
1 ml of deuterated water (pH 6.5 or pH 5.5) containing 5 mM
EDTA and stored at 220uC for further analysis by
31P-NMR. This
methodology was successfully used to measure phosphorylated
metabolites in L. lactis [55]. In S. pneumoniae ethanol extracts the
following phosphorylated metabolites were detected: G6P, FBP, 3-
PGA, PEP, a-Gal1P, a-G1P, TBP, UDP-Glc, UDP-N-acetylmur-
amoyl-pentapeptide, UDP-N-acetylglucosamine, UDP-glucos-
amine, CDP-choline, NAD
+, CTP, ATP and ADP. A small peak
due to fructose 6-phosphate was also detected, but its quantification
hampered by strong overlapping with a resonance due to the
medium component b-glycerophosphate. A weak resonance due to
dihydroxyacetone phosphate was present, but reliable integration
was not possible. The concentration limit for detection/quantifica-
tion of metabolites in ethanol extracts by
31P-NMR was
approximately 0.4–0.5 mM. Resonances were assigned by addition
of pure compounds to the extracts or on the basis of comparison
witha previous study [55]. Concentrations were calculated from the
areas of the resonances in
31P-spectra by comparison with the area
of a resonance due to methylphosphonic acid (Aldrich), added as an
internal standard, and after application of an appropriate factor for
correcting saturation of resonances. The reported concentration
values for intracellular phosphorylated compounds are averages of
three independent growth experiments.
31P-NMR spectra were recorded using a selective probe head
(
31P-SEX) at 37uC on a Bruker AVANCE II 500 MHz
spectrometer (Bruker BioSpin GmbH) by using standard Bruker
pulse programs. Spectra were referenced to the resonance of
external 85% H3PO4, designated at 0 ppm.
Capsular polysaccharide preparation and quantification
of the glucuronic acid content
Samples for the determination of the capsular glucuronic acid
amounts were prepared as follows: cells grown in CDM and
harvested in mid-exponential (OD600 of 0.3560.02) and transition-
to-stationary (OD600 of 1.360.1) phases of growth were centrifuged
(6,0006g,3 – 7 m i n ,4 uC), resuspended in PBS and pelleted at
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150 mM Tris-HCl (pH 7.0) and 1 mM MgSO4 and treated as
described elsewhere [56]. The supernatants derived from the two
centrifugations referred before were pooled and treated with 20%
(w/v) trichloroacetic acid for protein precipitation. After 2 h of
incubation in an ice bath proteins were pelleted and the
exopolysaccharides wereprecipitated with cold ethanol as in Ramos
et al. [55]. The glucuronic acid of capsule attached or loosely
attached (lost in centrifugations to the supernatants) to the cell wall
was quantified by the method for quantitative determination of
uronic acids as described by Blumenkrantz et al. [57].
Supporting Information
Figure S1 Growth profiles of D39 wild-type and the
isogenic ccpA mutant on Glc and Gal. (A) Schematic
overview of the ccpA gene and its flanking genes and the genetic
replacement of the ccpA gene with a spectinomycin marker in
strain D39. Hooked arrow, putative promoter; lollipop, putative
terminator; black area, ccpA gene replaced with a spectinomycin
cassette; numbers inside the genes, D39 SPD numbers; arrows and
numbers above the figure indicate primers used to construct the
D39DccpA mutant; zoomed area (inset), putative cre box, 235 and
210 promoter regions; the number of bp spacing these regions are
subscripted after {n}. (B and C) Growth of strains D39 (&),
D39DccpA (m) and D39DccpAnisRKpNZ[ccpA]( #) in CDM
containing 1% Glc (B) or 1% Gal (C) at 37uC in rubber-stoppered
static bottles without pH control (initial pH 6.5); growth curves as
in Figure 1, except that logarithmic scale was used for the y-axis.
The growth of the complemented strain was performed without
nisin in the medium. Optical densities at 600 nm (OD600) were
measured hourly. Each point of the growth curves is an average of
at least three independent experiments and the error was in all
cases below 15%. The growth rates for each strain are also
indicated and the values shown are averages 6 SD. The arrows
indicate the mid-exponential and transition-to-stationary time-
points at which D39 and D39DccpA samples were withdrawn for
transcriptomic and metabolic profiling analysis.
(TIF)
Table S1 Overview of all significantly up- or downreg-
ulated genes as determined by the DNA microarray
analysis of D39DccpA compared to D39 wild-type (yellow
columns). Only genes were included that have a ratio of
(D39DccpA/D39 wt) .1.5 or ,0.66, and .2.0 or ,0.5 in at least
one of the four conditions tested (See also Materials and Methods).
In case genes were also significantly up- or downregulated
(according to the same criteria) in the in silico comparison of Glc
compared to Gal, which was done for both the M and TS phases
and for both D39 wt and the D39DccpA, these data were also given
(green columns, ratios are Glc/Gal). In addition, putative cre sites
are given in columns AG to AJ. For more details, see column
headers. Glc=glucose, Gal=galactose, wt=D39 wild-type,
ccpA=D39DccpA, M=mid-exponential growth phase, TS=transi-
tion-to-stationary growth phase, bayes p.=bayesian p-value,
FDR=false discovery rate, COG=cluster of orthologous groups.
(XLS)
Table S2 Expression ratio of selected genes linked to
metabolic and virulence pathways (spd_0420 (pfl),
spd_0667 (sodA), spd_0790 (pyk), spd_1053 (lacE),
spd_1078 (ldh), spd_1504 (nanA) and spd_1634 (galK) as
determined by qRT-PCR in exponentially and transition
to stationary phases of growth. Samples were obtained as
described for the microarray experiments and the experiments
performed as in Materials and Methods. The qRT-PCR data were
normalized to the level of metG (spd_0689) cDNA and the data are
averages of four repeats.
(XLS)
Table S3 Subtable abstracted from Table S1, giving
only the genes in COG [G] (Carbohydrate transport and
metabolism). Putative substrates for carbohydrate transporters
regulated by CcpA are indicated as well. ABC, ATP binding
cassette transporter; PTS, phosphoenolpyruvate:carbohydrate
phosphotransferase system.
(XLS)
Table S4 Overview of all significantly (according to the
criteria as outlined in the legend for Table S1) up- or
downregulated genes as determined by the in silico DNA
microarray analysis of the signals in Glc compared to
the signals in Gal (Glc/Gal, green columns). In case genes
were also significantly up- or downregulated (according to the
same criteria) in the D39DccpA versus D39 wild-type comparison,
these data were also given (yellow columns). As in Table S1,
putative cre sites are given as well. For more details, see column
headers and legend Table S1.
(XLS)
Table S5 List of genes with putative cre sites, as
predicted and compiled in this study as described in
detail in the Materials and Methods.
(XLS)
Table S6 List of genes with putative cre sites that were
not significantly affected in the DNA microarray analy-
ses of D39DccpA compared to D39 wild-type.
(XLS)
Table S7 Subtable abstracted from Table S1, giving the
virulence genes regulated by CcpA. Gene names and
references are given as well.
(XLS)
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